Risk factors of 90-day rehospitalization following discharge of pediatric patients hospitalized with mycoplasma Pneumoniae pneumonia
- 260 Downloads
Among pediatric patients hospitalized for Mycoplasma pneumoniae pneumonia (MPP), the risk factors for 90-day readmission after discharge is undefined.
We conducted a retrospective observational study of patients <14 years of age who were discharged with a diagnosis of MPP between January 2016 and February 2017. We collected clinical, laboratory and radiographic variables at the time of initial admission. We assessed pneumonia-related readmission within 90-day after discharge. Risk factors independently associated with rehospitalization were identified using multiple logistic regression models.
Of the 424 MPP hospitalizations, 48 (11.3%) were readmitted within 90 days and were mainly diagnosed with pneumonia. Patients with younger age or coinfection with influenza A were more likely to be readmitted. In addition, compared with children without readmission, the readmission ones showed different clinical and laboratory characteristics at the index hospital admission. Multiple logistic regression analysis identified age (OR 0.815, 95%CI 0.706–0.940) and body temperature (OR 0.659, 95%CI 0.518–0.839) were significantly associated with lower risk of 90-day readmission. Coinfection with influenza was independently associated with a greater likelihood of 90-day readmission (OR 4.746, 95%CI 1.191–18.913).
Readmission after MPP are common and is related to patients’ age, body temperature and influenza A coinfection during initial hospital stay, indicating potential targets could be noticed to reduce the rehospitalization after pediatric MPP.
KeywordsMPP Rehospitalization Children
Community acquired pneumonia
- GeXP assay
GenomeLab Genetic Analysis System
- MP or M. pneumoniae
Reverse transcription polymerase chain reaction
Readmission of patients initially hospitalized for community acquired pneumonia (CAP) is relatively common [1, 2, 3]. Both of preventable and non-preventable risk factors have been explored, but the main participants in these studies were the elderly and patients with multiple comorbidities, not children [4, 5, 6, 7].
The previous three studies described 14 days , 30 days  readmission rates (range of 1.5–8%) for children with pneumonia or lower respiratory infections (LRIs) . In these studies, one of the consistent identified risk factors was chronic medical conditions. But in fact, a large number of children who are rehospitalized are caused by acute diseases . If patients with chronic conditions are excluded, the difficulty is to detect readmission risk factors associated with the current acute infection. In addition, children with LRIs, a relatively broad diagnosis, or pneumonia with an underlying chronic illness may bring compounding factors conferring susceptibility for readmission. A promising approach to resolve this problem is to narrow down study sample according to the pathogenic or clinical features, such as Mycoplasma pneumoniae pneumonia (MPP), which accounts for up to 40% pediatric CAP , and its diagnosis is based on etiology and clinical evidence, thereby elevating the power to detect readmission risk factors associated with the current acute infections. We hypothesized that MPP children may have different characteristic during the first hospital stay between patients with and without readmission. This study was therefore conducted to enroll pediatric MPP patients without other underlying chronic diseases.
Our aims were to (1) describe the incidence and type of readmission after MPP discharge, (2) investigate the differences between patients with and without readmission at the initial hospital stay, (3) examine the risk factors for 90-day pneumonia-related rehospitalization.
Material and methods
This retrospective, observational study was conducted at Children’s Hospital of Hebei Province, a 1200-bed teaching hospital in Hebei Province (northern China) that serves a population of 70,000,000 inhabitants, including 18.5% children. Patients with a discharge diagnosis of MPP were evaluated. The project was approved by the ethics review board of the hospital. Because data in this report were collected from inpatient electronic medical records, there was no need to collect new specimens or the corresponding written informed consent.
Children ≤14 years of age who were admitted to Children’s Hospital of Hebei Province with a diagnosis of MPP from January 2016, to February 2017, were consecutively enrolled into the study. The diagnosis of MPP needs to meet the following first 2 points plus either third or fourth point : 1) a new infiltrate on a chest radiograph; 2) fever, cough and abnormal lung auscultation; 3) positive serology laboratory results specific MP antibody titer≥1:160 detected by a micro-particle agglutination test ; 4) positive PCR laboratory results, MP-DNA positive detected in sputum, nasopharyngeal aspirate or bronchoalveolar lavage fluid (BALF) by PCR . Patients were excluded from the study if they were known to be chronically immunosuppressed, or with chronic cardiopulmonary conditions or had been hospitalized for the previous 14 days. If a patient had more than one episode of pneumonia during the index hospitalization, only the first one was included in the analysis.
Data and specimen collection
The following patient characteristics were evaluated: age, sex, signs and symptom before admission (wheezing, cough and diarrhea). The laboratory data and radiological findings were also measured and retrospectively investigated from inpatient electronic medical records system. Clinical symptoms included wheezing, cough and diarrhea. Ill day and febrile day before admission, hospital days, febrile day and readmission rate were also recorded. The time frame of readmission was set as 90-day from original discharge. Body temperature was examined at the beginning of admission and every 8 h thereafter. A febrile day was defined as the body temperature exceeded 38.0 °C at least once .
Patients were asked to cough, and the expectorated sputum was collected. If the child is too young to cough, a sterile negative pressure suction catheter is applied to obtain the oropharyngeal suction (OPS). The storage, transportation and nucleic acid extraction procedure were reported elsewhere . The paired serum samples were taken at the presentation of pneumonia and at least 7 days after the first collection of serum. The serum was obtained from 2 mL whole blood by the separation gel tube.
Detection of MP-DNA and MP-antibody
The GeXP assay (GenomeLab GeXP Genetic Analysis System) was performed on all specimens for the 13 type/subtypes of common respiratory pathogens including M. pneumoniae. The multiplex-PCR was performed as previously described elsewhere . The bacteria infection was examined by standard culture methods from sputum specimens . The determination of MP-specific antibody was performed using a commercially available micro-particle agglutination test Serodia-MycoII kit (Fujirebio, Tokyo, Japan) . Diagnosis criteria were defined as ≥4-found rising for paired sera or single serum of titer ≥1:160 .
The chi-squared test was used to compare categorical variable in subgroups. And for those continuous variables with normal and non-normal distributions, mean or median values were compared using the t test or Mann-Whitney U test. SPSS 19.0 statistics package (SPSS Inc., Chicago, USA) software was used for all statistical analysis. p < 0.05 was considered statistically significant.
Patients enrollment and readmission diagnoses
The diagnosis of 90-days pneumonia-related readmission
Refractory Mycoplasma pneumoniae pneumonia
Characteristics of children
Patient characteristic on index visit are different between children with and without readmission
n = 48
n = 376
Before and after admission
Ill day before admission
Febrile day before admission
Body Temperature on admission
Febrile day after admission
Clinical manifestation at presentation
Light diffuse shadowing
Severity on admission
Different laboratory data on index hospitalization between patients with and without readmission
n = 48
n = 376
9.9 (7.6, 13.2)
49.2 ± 17.5
55.6 ± 16.3
40.4 ± 16.0
31.9 (21.3, 43.6)
7.1 ± 2.6
4.2 (1.0, 11.4)
261.5 (228.7, 299.2)
211.5 (189.0, 236.2)
The coinfection pathogens in patients with 90-days readmission
Respiratory syncytial virus
Multiple logistic regression analysis
Stepwise logistic regression for the related factors associated with readmission
Influenza A coinfection
Body Temperature on admission
Generally, readmissions after pneumonia are common. In terms of safety and cost, it is important to assess the relationship between initial hospital stay and readmission outcomes [9, 20]. Although the investigation of risk factors is challenging, significant progress has been made on the elderly, that the readmission was found to be largely depends on the comorbidities and factors external to the patient [1, 2, 4, 21]. This has also been observed in children, and one of the identified risk factors is chronic medical conditions such as underlying pulmonary or cardiovascular disease [9, 10, 11]. To date, research on potential risk factors for readmission has hardly focused on current acute infections or specific pathogens. Because pneumonia is a complex heterogenous disease that can be caused by a variety of pathogens, 1) studying pneumonia patients with the same infectious pathogen can reduce heterogeneity, 2) exclusion of patients with underlying diseases can improve the ability to detect readmission risk factors associated with the current acute infections. Therefore, we investigated the rate of 90-day pneumonia-related readmission in hospitalized children with MPP who had no basal or chronic disease. After comparing the clinical information of the first hospitalization between patients who were readmitted and not readmitted to the hospital, we obtained the following findings: 1) 48 (11.3%) children were readmitted within 90 days of the first MPP discharge; 2) at the index hospital stay, readmission patients manifested different characteristics; 3) co-infection with influenza A increased the risk of 90-day readmission.
In this study, the readmission rate after MPP discharge was 11.6%. Pneumonia and bronchial pneumonia were the majority diagnoses on readmission. Nakamura et al. identified that 5.5% cases readmitted after LRI hospitalization, and the most common readmission diagnose was LRI (48.2%) . Similar to the pattern observed by Neuman and colleagues, nearly half of the 8% of patients who were discharged from initial pneumonia hospitalization were also associated with pneumonia . Previous work has shown that 30% pediatric readmissions are potentially preventable, especially the index admission and readmission are causally related . This is one of the reasons we focus on pneumonia-related readmission. Meanwhile, we observed a trend in patients with relatively mild radiological symptoms and lower levels of acute inflammatory markers that are more likely to be rehospitalized. The cause of this phenomenon may be related to two points, including different host immunity and treatment strategies. First, clinical presentation depends on the host’s immune response, rather than direct microbial destruction during the progression of M. pneumoniae infection . Patient with a reduced immune system, such as younger ones who have had less time to develop immunity, may be characterized by mild clinical symptoms but with a prolonged recovery period. Second, pediatricians will adopt different treatment strategies for patients with severe or mild symptoms. Patients at risk of readmission may receive different medication times due to M. pneumoniae virulence or host immune response.
In this present study, we found that influenza coinfection increased the risk of readmission, which is consistent with previous investigations of children with complicated pneumonia. William et al. found that although there was a trend to increase mortality, patients with flu coinfection were less likely to readmitted in 2 weeks readmission, . Brogan et al. observed that children who were infected with influenza during the initial hospital stay had a higher rate of readmission than children who were not infected with influenza . Regarding the elderly, researches show that influenza vaccination is associated with a lower likelihood of readmission [5, 26, 27]. In view of these findings, influenza vaccination should be promoted not only in pediatric hospitals at CAP discharge, but also for all people, particularly in high risk groups including children under 5 years old, and those with asthma. In addition, we observed that younger children are liable to readmit, which is consistent with previous findings, demonstrating a higher rate of readmission for children under 1 year of age [9, 28]. As explained by Gay JC et al., pneumonia in young patients usually has protracted and waning course, leading to structural lung damage or immune paresis and further pneumonia episodes . Second, younger patients may be more prone to new infections due to higher exposure during nursery attendance and the previous lack of immunity to respiratory pathogens, which will be resulting in rehospitalization. Furthermore, Studies of children with asthma have found that the rate of readmission of children under 1 year of age in higher, further highlighting the need to improve inpatient decision-making for young patients.
To our knowledge, this is the first study to explore the factors of readmission for pediatric MPP patients. Further research in larger cohorts is needed to validate the data. Meanwhile, some questions remain to be answered: first, it has been reported that pneumonia attributed to potentially antibiotic-resistant bacteria is associated with an increased risk of readmission , we strongly felt that macrolide resistance has a role on the risk of readmission, but what is the role? Second, coinfection with influenza A will increase the risk of readmission, what is the underlying mechanism?
This study has several limitations. First, the sample size may be small because only 48 patients were rehospitalized within 90 days. Second, if the child is readmitted to another institution, we may underestimate the rate of readmission. Third, in the absence of the information after first discharge, the interference factor related to age may be introduced into this research, as the rehospitalization may be caused by a new infection during nursery attendance. Fourth, other clinical information to document severity is not included in the study, such as oxygen requirement, antibiotic or corticoid duration. Fifth, a potential limitation would be that the serological assays have a high false positive detection rate and it is difficult to obtain the second serum. In our report, only 6 children provided paired sera, and the other 123 patients (123/424, 29%) had positive serological results with only a single high titer, but the PCR results were negative. Last, although there were significant differences in CRP, LDH levels or patient characteristics between rehospitalized and non-rehospitalized patients, these factors cannot be controlled and of low value in clinical practice.
In conclusion, rehospitalization after MPP is relatively common and is related to patients’ age and co-infected pathogens. Careful attention to clinical variables may reduce the frequency of rehospitalization of pediatric patients after discharge on MPP.
We sincerely thank all the participants for their support. We also thank Dr. Sukun Lu and Lijie Cao from the No.2 Department of Respiratory, Children’s Hospital of Hebei Province, for their help to record the clinical information.
LW performed the statistical analysis and drafted the manuscript. ZF participated in the validation. GL and JL participated in the design of the study. GL conceived of the study, and participated in its design and coordination, JS helped to draft the manuscript. All authors read and approved the final manuscript.
Ethics approval and consent to participate
The protocols used in this retrospective study was reviewed and approved by the institutional review board of Children’s Hospital of Hebei Province. Because there was no need to collect new specimens and the clinical data was de-identified, so the consent was waived by IRB of Children’s Hospital of Hebei Province. After obtaining the IRB’ permission, we can review patient records and use these data, which were all de-identified.
Consent for publication
All the authors declared that they have no competing interests.
- 2.Toledo D, Soldevila N, Torner N, Perez-Lozano MJ, Espejo E, Navarro G, Egurrola M, Dominguez A. On-behalf of the project FISPIWG: factors associated with 30-day readmission after hospitalisation for community-acquired pneumonia in older patients: a cross-sectional study in seven Spanish regions. BMJ Open. 2018;8(3):e020243.CrossRefGoogle Scholar
- 7.Adamuz J, Viasus D, Camprecios-Rodriguez P, Canavate-Jurado O, Jimenez-Martinez E, Isla P, Garcia-Vidal C, Carratala J. A prospective cohort study of healthcare visits and rehospitalizations after discharge of patients with community-acquired pneumonia. Respirology. 2011;16(7):1119–26.CrossRefGoogle Scholar
- 13.Nelson S, Belknap SM, Carlson RW, Dale D, DeBoisblanc B, Farkas S, Fotheringham N, Ho H, Marrie T, Movahhed H, et al. A randomized controlled trial of filgrastim as an adjunct to antibiotics for treatment of hospitalized patients with community-acquired pneumonia. CAP study group. J Infect Dis. 1998;178(4):1075–80.CrossRefGoogle Scholar
- 15.Templeton KE, Scheltinga SA, Graffelman AW, Van Schie JM, Crielaard JW, Sillekens P, Van Den Broek PJ, Goossens H, Beersma MF, Claas EC. Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of mycoplasma pneumoniae. J Clin Microbiol. 2003;41(9):4366–71.CrossRefGoogle Scholar
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.